Patents by Inventor Kettner John Frederick Griswold, Jr.

Kettner John Frederick Griswold, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11725222
    Abstract: Cleavable nucleotide analogs are provided. The nucleotide analog includes a nucleotide molecule attached to a cleavable moiety wherein the cleavable moiety comprises a protective group and/or a linker attached to a fluorophore. The cleavable moiety is linked to the oxygen atom of the 3?-OH of the pentose of the nucleotide molecule. The nucleotide analogs can be used in making polynucleotide molecules using template independent polymerases. The nucleotide analogs can act as reversible terminators during DNA sequencing by synthesis. The cleavage of the cleavable moiety restores a free 3?-OH functional group allowing growth of the polynucleotide molecule. The general structures as well as proposed synthetic schemes for the nucleotide analogs are also provided.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: August 15, 2023
    Assignee: President and Fellows of Harvard College
    Inventors: Kettner John Frederick Griswold, Jr., Richard E. Kohman, George M. Church, Jonathan Rittichier
  • Patent number: 10975407
    Abstract: A composition for use in extending a molecular chain includes a carrier group and a payload group. The carrier group comprising a signaling group and a blocking group. A first bond bonds the payload group to the carrier group and a second bond bonds the signaling group to the blocking group. The first and second bonds are selectively cleavable such that the first bond is cleavable without cleaving the second bond. The payload group is to be attached to the molecular chain, while the blocking group is to block further attachments to the molecular chain once the payload group has been attached. The signaling group comprises a photon emitter that emits a signature photon in response to interrogation by an interrogatory photon. The carrier group transitions from a loaded state to an empty state upon cleavage of the first covalent bond.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: April 13, 2021
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Melissa M. Sprachman, Andrew P. Magyar, Kettner John Frederick Griswold, Jr.
  • Patent number: 10774366
    Abstract: A method for making a polynucleotide is provided including (a) delivering one or more reaction reagents including an error prone or template independent DNA polymerase, cations and a selected nucleotide to a reaction site including an initiator sequence having a terminal nucleotide for a time period and under conditions capable of covalently adding one or more of the selected nucleotide to the terminal nucleotide at the 3? end of the initiator such that the selected nucleotide becomes a terminal nucleotide, and (b) determining whether the selected nucleotide has been added to the terminal nucleotide, wherein if the selected nucleotide has not been added to the terminal nucleotide, then repeating step (a) until the selected nucleotide has been added, and (c) repeating steps (a) and (b) until the polynucleotide is formed.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: September 15, 2020
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Kettner John Frederick Griswold, Jr.
  • Publication number: 20200080122
    Abstract: Cleavable nucleotide analogs are provided. The nucleotide analog includes a nucleotide molecule attached to a cleavable moiety wherein the cleavable moiety comprises a protective group and/or a linker attached to a fluorophore. The cleavable moiety is linked to the oxygen atom of the 3?-OH of the pentose of the nucleotide molecule. The nucleotide analogs can be used in making polynucleotide molecules using template independent polymerases. The nucleotide analogs can act as reversible terminators during DNA sequencing by synthesis. The cleavage of the cleavable moiety restores a free 3?-OH functional group allowing growth of the polynucleotide molecule. The general structures as well as proposed synthetic schemes for the nucleotide analogs are also provided.
    Type: Application
    Filed: November 30, 2017
    Publication date: March 12, 2020
    Inventors: Kettner John Frederick Griswold, Jr., Richie Kohman, George M. Church, Jonathan Rittichier
  • Publication number: 20190360013
    Abstract: An enzymatic method of making a polynucleotide is provided. The method includes combining a selected nucleotide triphosphate, one or more cations, a template-independent polymerase, and an associated processivity factor in an aqueous reaction medium including a target substrate comprising an initiator sequence and having a 3? terminal nucleotide attached to a single stranded portion, such that the template-independent polymerase and the associated processivity factor interact with the target substrate under conditions which covalently add one or more of the selected nucleotide triphosphate to the 3? terminal nucleotide. Also provided are mutant template-independent polymerases having a processivity factor attached thereto.
    Type: Application
    Filed: December 4, 2017
    Publication date: November 28, 2019
    Applicant: President and Fellows of Harvard College
    Inventors: Kettner John Frederick GRISWOLD, JR., Brian M. TURCZYK, Daniel Jordan WIEGAND, George M. CHURCH, Alexander GARRUSS
  • Publication number: 20190323050
    Abstract: Methods and apparatus of modulating polynucleotide synthesis are provided. The methods include delivering reagents comprising enzymes, nucleotides and ions to oligonucleotide primers wherein the reagents catalyze incorporation of the nucleotides to 3? ends of the oligonucleotide primers, and modulating incorporation of the nucleotides to the 3? ends of the oligonucleotide primers. Polynucleotide synthesis is modulated by modulating presence or absence of catalytic cation cofactors to provide sequence defined synthesis of polynucleotides. In certain embodiments, the polynucleotides encode information.
    Type: Application
    Filed: December 21, 2017
    Publication date: October 24, 2019
    Applicant: President and Fellows of Harvard College
    Inventors: Kettner John Frederick Griswold, Jr., Howon Lee, George M. Church
  • Publication number: 20190323049
    Abstract: A composition for use in extending a molecular chain includes a carrier group and a payload group. The carrier group comprising a signaling group and a blocking group. A first bond bonds the payload group to the carrier group and a second bond bonds the signaling group to the blocking group. The first and second bonds are selectively cleavable such that the first bond is cleavable without cleaving the second bond. The payload group is to be attached to the molecular chain, while the blocking group is to block further attachments to the molecular chain once the payload group has been attached. The signaling group comprises a photon emitter that emits a signature photon in response to interrogation by an interrogatory photon. The carrier group transitions from a loaded state to an empty state upon cleavage of the first covalent bond.
    Type: Application
    Filed: May 22, 2017
    Publication date: October 24, 2019
    Inventors: Melissa M. Sprachman, Andrew P. Magyar, Kettner John Frederick Griswold, Jr.
  • Publication number: 20190062804
    Abstract: A method for making a polynucleotide is provided including (a) delivering one or more reaction reagents including an error prone or template independent DNA polymerase, cations and a selected nucleotide to a reaction site including an initiator sequence having a terminal nucleotide for a time period and under conditions capable of covalently adding one or more of the selected nucleotide to the terminal nucleotide at the 3? end of the initiator such that the selected nucleotide becomes a terminal nucleotide, and (b) determining whether the selected nucleotide has been added to the terminal nucleotide, wherein if the selected nucleotide has not been added to the terminal nucleotide, then repeating step (a) until the selected nucleotide has been added, and (c) repeating steps (a) and (b) until the polynucleotide is formed.
    Type: Application
    Filed: March 9, 2017
    Publication date: February 28, 2019
    Inventors: George M. Church, Kettner John Frederick Griswold, Jr.